Long-Term Efficacy and Safety of Single-Agent Ibrutinib at 3 Years Follow-up in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) by O’Brien, Susan M., MD, Jones, Jeffrey A., MD, MPH, Furman, Richard R., MD, Coutre, Steven E., MD, Flinn, Ian W., MD, PhD, Burger, Jan A., MD, PhD, Blum, Kristie A., MD, Sharman, Jeff P., MD, Wierda, William G., MD, PhD, Zhao, Weiqiang, MD, PhD, Heerema, Nyla A., PhD, Johnson, Amy J., PhD, Tran, Anh, BS, Zhou, Cathy, Bilotti, Elizabeth, MSN, James, Danelle F., MD, MAS, Byrd, John C., MD

Get full text

Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval by Moayeri, Sharon E., MD, MPH, Coutre, Steven E., MD, Ramirez, Edward J., MD, Westphal, Lynn M., MD

Get full text

Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study by O'Brien, Susan, Prof, Jones, Jeffrey A, MD, Coutre, Steven E, Prof, Mato, Anthony R, MD, Hillmen, Peter, Prof, Tam, Constantine, MD, Österborg, Anders, Prof, Siddiqi, Tanya, MD, Thirman, Michael J, MD, Furman, Richard R, MD, Ilhan, Osman, Prof, Keating, Michael J, Prof, Call, Timothy G, MD, Brown, Jennifer R, MD, Stevens-Brogan, Michelle, MSc, Li, Yunfeng, PhD, Clow, Fong, ScD, James, Danelle F, MD, Chu, Alvina D, MD, Hallek, Michael, Prof, Stilgenbauer, Stephan, Prof

Get full text

Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial by O'Brien, Susan, Prof, Furman, Richard R, MD, Coutre, Steven E, Prof, Sharman, Jeff P, MD, Burger, Jan A, MD, Blum, Kristie A, MD, Grant, Barbara, MD, Richards, Donald A, MD, Coleman, Morton, Prof, Wierda, William G, MD, Jones, Jeffrey A, MD, Zhao, Weiqiang, MD, Heerema, Nyla A, Prof, Johnson, Amy J, PhD, Izumi, Raquel, PhD, Hamdy, Ahmed, MD, Chang, Betty Y, PhD, Graef, Thorsten, MD, Clow, Fong, ScD, Buggy, Joseph J, PhD, James, Danelle F, MD, Byrd, John C, Prof

Get full text

Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Results From the Randomized Phase III RESONATE™ (PCYC-1112) Tri... by Brown, J. Jennifer R., MD, PhD, Byrd, John C., MD, O’Brien, Susan, MD, Barrientos, Jacqueline C., MD, Kay, Neil E., MD, Reddy, Nishitha M., MBBS, MD, Coutre, Steven, MD, Tam, Constantine S., MBBS, MD, Mulligan, Stephen, MBBS, PhD, FRACP, FRCPA, Jaeger, Ulrich, MD, Devereux, Stephen, PhD, FRCP, FRCPath, Barr, Paul M., MD, Furman, Richard, MD, Kipps, Thomas, MD, PhD, Cymbalista, Florence, MD, PhD, Fardis, Maria, PhD, MBA, McGreivy, Jesse, MD, Clow, Fong, DSc, James, Danelle F., MD, MAS, Hillmen, Peter, MD, PhD, FRCP, FRCPath

Get full text

Immune Characterization of Ibrutinib Therapy Following Allohct That Provides GVL Benefit without Gvhd by Sahaf, Bita, Ryan, Christine E, Rezvani, Andrew, Nakasone, Hideki, MD, PhD, Otani, Joanne, Coutre, Steven, Lowsky, Robert, MD, Negrin, Robert, MD, Miklos, David B

Get full text